Brave Asset Management Inc Crispr Therapeutics Ag Transaction History
Brave Asset Management Inc
- $368 Million
- Q2 2025
A detailed history of Brave Asset Management Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Brave Asset Management Inc holds 13,534 shares of CRSP stock, worth $780,641. This represents 0.18% of its overall portfolio holdings.
Number of Shares
13,534
Previous 5,409
150.21%
Holding current value
$780,641
Previous $184,000
257.61%
% of portfolio
0.18%
Previous 0.06%
Shares
11 transactions
Others Institutions Holding CRSP
# of Institutions
481Shares Held
63.9MCall Options Held
2.16MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$587 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$350 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$219 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$160 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.54MShares$147 Million1.16% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.5B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....